153 related articles for article (PubMed ID: 32696043)
1. Association of functional (GA)n microsatellite polymorphism in the FLI1 gene with susceptibility to human systemic sclerosis.
Yamashita K; Kawasaki A; Matsushita T; Furukawa H; Kondo Y; Okiyama N; Nagaoka S; Shimada K; Sugii S; Katayama M; Hirohata S; Okamoto A; Chiba N; Suematsu E; Setoguchi K; Migita K; Sumida T; Tohma S; Hamaguchi Y; Hasegawa M; Sato S; Kawaguchi Y; Takehara K; Tsuchiya N
Rheumatology (Oxford); 2020 Nov; 59(11):3553-3562. PubMed ID: 32696043
[TBL] [Abstract][Full Text] [Related]
2. Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.
Taniguchi T; Asano Y; Nakamura K; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S
J Rheumatol; 2017 Aug; 44(8):1198-1205. PubMed ID: 28507181
[TBL] [Abstract][Full Text] [Related]
3. Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.
Miyagawa T; Taniguchi T; Saigusa R; Fukayama M; Takahashi T; Yamashita T; Hirabayashi M; Miura S; Nakamura K; Yoshizaki A; Sato S; Asano Y
Rheumatology (Oxford); 2020 Aug; 59(8):2005-2015. PubMed ID: 31782787
[TBL] [Abstract][Full Text] [Related]
4. A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis.
Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
Exp Dermatol; 2016 Apr; 25(4):287-92. PubMed ID: 26661692
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis.
Asano Y
Int J Biochem Cell Biol; 2015 Oct; 67():86-91. PubMed ID: 26055516
[TBL] [Abstract][Full Text] [Related]
6. A GA microsatellite in the Fli1 promoter modulates gene expression and is associated with systemic lupus erythematosus patients without nephritis.
Morris EE; Amria MY; Kistner-Griffin E; Svenson JL; Kamen DL; Gilkeson GS; Nowling TK
Arthritis Res Ther; 2010; 12(6):R212. PubMed ID: 21087477
[TBL] [Abstract][Full Text] [Related]
7. CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.
Taniguchi T; Miyagawa T; Toyama S; Yamashita T; Nakamura K; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S; Asano Y
Exp Dermatol; 2018 Sep; 27(9):1030-1037. PubMed ID: 29947047
[TBL] [Abstract][Full Text] [Related]
8. Bushen Yijing Decoction (BSYJ) exerts an anti-systemic sclerosis effect via regulating MicroRNA-26a /FLI1 axis.
Cheng Z; Zhang J; Deng W; Lin S; Li D; Zhu K; Qi Q
Bioengineered; 2021 Dec; 12(1):1212-1225. PubMed ID: 33843426
[TBL] [Abstract][Full Text] [Related]
9. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
Wang Y; Fan PS; Kahaleh B
Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.
Noda S; Asano Y; Nishimura S; Taniguchi T; Fujiu K; Manabe I; Nakamura K; Yamashita T; Saigusa R; Akamata K; Takahashi T; Ichimura Y; Toyama T; Tsuruta D; Trojanowska M; Nagai R; Sato S
Nat Commun; 2014 Dec; 5():5797. PubMed ID: 25504335
[TBL] [Abstract][Full Text] [Related]
11. [A Uuifying hypothesis for the pathogenesis of systemic sclerosis based on the deficiency of transcription factor Fli1 - the development of a new animal model of systemic sclerosis -].
Asano Y
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):475-87. PubMed ID: 25748132
[TBL] [Abstract][Full Text] [Related]
12. Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects.
Bujor AM; El Adili F; Parvez A; Marden G; Trojanowska M
Front Immunol; 2020; 11():800. PubMed ID: 32508810
[TBL] [Abstract][Full Text] [Related]
13. A potential contribution of trappin-2 to the development of vasculopathy in systemic sclerosis.
Miyagawa T; Asano Y; Saigusa R; Hirabayashi M; Yamashita T; Taniguchi T; Takahashi T; Nakamura K; Miura S; Yoshizaki A; Miyagaki T; Sato S
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):753-760. PubMed ID: 30520152
[TBL] [Abstract][Full Text] [Related]
14. Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy.
Asano Y; Stawski L; Hant F; Highland K; Silver R; Szalai G; Watson DK; Trojanowska M
Am J Pathol; 2010 Apr; 176(4):1983-98. PubMed ID: 20228226
[TBL] [Abstract][Full Text] [Related]
15. A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis.
Taniguchi T; Miyagawa T; Tamaki Z; Nakamura K; Yamashita T; Saigusa R; Takahashi T; Toyama T; Ichimura Y; Yoshizaki A; Tada Y; Sugaya M; Kadono T; Sato S; Asano Y
Arch Dermatol Res; 2017 Dec; 309(10):833-842. PubMed ID: 29038846
[TBL] [Abstract][Full Text] [Related]
16. Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.
Noda S; Asano Y; Takahashi T; Akamata K; Aozasa N; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
Rheumatology (Oxford); 2013 May; 52(5):790-9. PubMed ID: 23287360
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis.
Akamata K; Asano Y; Taniguchi T; Yamashita T; Saigusa R; Nakamura K; Noda S; Aozasa N; Toyama T; Takahashi T; Ichimura Y; Sumida H; Tada Y; Sugaya M; Kadono T; Sato S
Rheumatology (Oxford); 2015 Jul; 54(7):1308-16. PubMed ID: 25539827
[TBL] [Abstract][Full Text] [Related]
18. A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis.
Saigusa R; Asano Y; Taniguchi T; Yamashita T; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
Exp Dermatol; 2015 Feb; 24(2):127-32. PubMed ID: 25421497
[TBL] [Abstract][Full Text] [Related]
19. Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis.
Ichimura Y; Asano Y; Akamata K; Takahashi T; Noda S; Taniguchi T; Toyama T; Aozasa N; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
Arch Dermatol Res; 2014 May; 306(4):331-8. PubMed ID: 24292093
[TBL] [Abstract][Full Text] [Related]
20. Double heterozygous mice for Klf5 and Fli1 genes: a new animal model of systemic sclerosis recapitulating its three cardinal pathological features.
Asano Y
Med Mol Morphol; 2015 Sep; 48(3):123-8. PubMed ID: 25986681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]